Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data (Q30779447)

26 June 2017

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data (English)

1 reference

26 June 2017

1 reference

metastatic breast cancer

1 reference

0 references

3

Tanja Fehm

0 references

Erich-Franz Solomayer

37

Erich-Franz Solomayer

0 references

Franziska Meier-Stiegen

20

Franziska Meier-Stiegen

0 references

François-Clément Bidard

1

François-Clément Bidard

0 references

Leticia De Mattos-Arruda

16

Leticia De Mattos-Arruda

0 references

Dieter Peeters

Dieter J Peeters

2

0 references

Sarah-Jane Dawson

Sarah-Jane Dawson

28

0 references

Jose A Garcia-Saenz

Jose A Garcia-Saenz

9

0 references

Elisabetta Munzone

Elisabetta Munzone

32

0 references

Rita Zamarchi

Rita Zamarchi

14

0 references

Camillo Almici

Camillo Almici

35

0 references

Daniele Generali

Daniele Generali

8

0 references

Stefan Michiels

Stefan Michiels

43

0 references

Eduardo Díaz-Rubio

Eduardo Diaz-Rubio

26

0 references

Jorge Reis-Filho

40

Jorge S Reis-Filho

1 reference

26 June 2017

11

Carlos Caldas

1 reference

26 June 2017

34

Sofia Agelaki

1 reference

26 June 2017

41

Klaus Pantel

1 reference

26 June 2017

31

Wolfgang Janni

1 reference

26 June 2017

Franco Nolé

4

1 reference

26 June 2017

Rafael Gisbert-Criado

5

1 reference

26 June 2017

Dimitrios Mavroudis

6

1 reference

26 June 2017

Salvatore Grisanti

7

1 reference

26 June 2017

Justin Stebbing

10

1 reference

26 June 2017

Paola Gazzaniga

12

1 reference

26 June 2017

Luis Manso

13

1 reference

26 June 2017

Angela Fernandez de Lascoiti

15

1 reference

26 June 2017

Leticia De Mattos-Arruda

16

1 reference

26 June 2017

Michail Ignatiadis

17

1 reference

26 June 2017

Ronald Lebofsky

18

1 reference

26 June 2017

Steven J van Laere

19

1 reference

26 June 2017

Maria-Teresa Sandri

21

1 reference

26 June 2017

Jose Vidal-Martinez

22

1 reference

26 June 2017

Eleni Politaki

23

1 reference

26 June 2017

Francesca Consoli

24

1 reference

26 June 2017

Alberto Bottini

25

1 reference

26 June 2017

Jonathan Krell

27

1 reference

26 June 2017

Cristina Raimondi

29

1 reference

26 June 2017

Annemie Rutten

30

1 reference

26 June 2017

Vicente Carañana

33

1 reference

26 June 2017

Luc Dirix

36

1 reference

26 June 2017

Laura Zorzino

38

1 reference

26 June 2017

Helene Johannes

39

1 reference

26 June 2017

Jean-Yves Pierga

42

1 reference

26 June 2017

11 March 2014

1 reference

Lancet Oncology Commission

26 June 2017

1 reference

26 June 2017

15

1 reference

26 June 2017

406-414

1 reference

26 June 2017

4

1 reference

Considerations in the development of circulating tumor cell technology for clinical use

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Analysis of circulating tumor DNA to monitor metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Going with the flow: from circulating tumor cells to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970069-5

7 January 2021

10.1016/S1470-2045(14)70069-5

Identifiers

DOI

1 reference

26 June 2017

1 reference